183 related articles for article (PubMed ID: 24713261)
1. Attenuated A20 expression of acute myeloid leukemia-derived dendritic cells increased the anti-leukemia immune response of autologous cytolytic T cells.
Zhang X; Su Y; Song H; Yu Z; Zhang B; Chen H
Leuk Res; 2014 Jun; 38(6):673-81. PubMed ID: 24713261
[TBL] [Abstract][Full Text] [Related]
2. Attenuated expression of A20 markedly increases the efficacy of double-stranded RNA-activated dendritic cells as an anti-cancer vaccine.
Breckpot K; Aerts-Toegaert C; Heirman C; Peeters U; Beyaert R; Aerts JL; Thielemans K
J Immunol; 2009 Jan; 182(2):860-70. PubMed ID: 19124729
[TBL] [Abstract][Full Text] [Related]
3. [The T cells activated by dendritic cells derived from AML cells: a study of their cytotoxic effect on autologous AML cells].
Xiang B; Li SF; Zhou J; Mao YQ; Yang YM; Liu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):784-7. PubMed ID: 15573754
[TBL] [Abstract][Full Text] [Related]
4. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
5. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].
He X; You S; Bian S
Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):629-32. PubMed ID: 16200709
[TBL] [Abstract][Full Text] [Related]
6. [In vitro anti-leukemia activity of cord blood original cytotoxic T lymphocytes].
Zeng LJ; Tan H
Ai Zheng; 2005 Apr; 24(4):419-24. PubMed ID: 15820063
[TBL] [Abstract][Full Text] [Related]
7. Induction of leukemia-specific CD8+ cytotoxic T cells with autologous myeloid leukemic cells maturated with a fiber-modified adenovirus encoding TNF-alpha.
Saudemont A; Corm S; Wickham T; Hetuin D; Quesnel B
Mol Ther; 2005 Jun; 11(6):950-9. PubMed ID: 15922966
[TBL] [Abstract][Full Text] [Related]
8. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Silencing of A20 via TLR9-Mediated Targeted SiRNA Delivery Potentiates Antitumor Immune Response.
Braun FC; van den Brandt J; Thomas S; Lange S; Schrank J; Gand C; Przybylski GK; Schmoeckel K; Bröker BM; Schmidt CA; Grabarczyk P
PLoS One; 2015; 10(9):e0135444. PubMed ID: 26327508
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC.
Nourizadeh M; Masoumi F; Memarian A; Alimoghaddam K; Moazzeni SM; Yaghmaie M; Hadjati J
Target Oncol; 2014 Sep; 9(3):225-37. PubMed ID: 23852664
[TBL] [Abstract][Full Text] [Related]
12. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
[TBL] [Abstract][Full Text] [Related]
13. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
Lee JJ; Choi BH; Nam JH; Park MS; Song WH; Yang DH; Kim YK; Cho SH; Chung IJ; Park KS; Lee IK; Kim HJ
J Clin Apher; 2004; 19(3):130-6. PubMed ID: 15493054
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger protein A20 inhibits maturation of dendritic cells resident in rat liver allograft.
Dai FZ; Yang J; Chen XB; Xu MQ
J Surg Res; 2013 Aug; 183(2):885-93. PubMed ID: 23481562
[TBL] [Abstract][Full Text] [Related]
15. Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia.
Woiciechowsky A; Regn S; Kolb HJ; Roskrow M
Leukemia; 2001 Feb; 15(2):246-55. PubMed ID: 11236940
[TBL] [Abstract][Full Text] [Related]
16. A20 expression in dendritic cells protects mice from LPS-induced mortality.
Xuan NT; Wang X; Nishanth G; Waisman A; Borucki K; Isermann B; Naumann M; Deckert M; Schlüter D
Eur J Immunol; 2015 Mar; 45(3):818-28. PubMed ID: 25472594
[TBL] [Abstract][Full Text] [Related]
17. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
[TBL] [Abstract][Full Text] [Related]
19. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
20. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
Kunter U; Daniel S; Arvelo MB; Choi J; Shukri T; Patel VI; Longo CR; Scali ST; Shrikhande G; Rocha E; Czismadia E; Mottley C; Grey ST; Floege J; Ferran C
Kidney Int; 2005 Oct; 68(4):1520-32. PubMed ID: 16164629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]